Transgene SA
TRGNF
$0.70
-$0.89-55.98%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -61.58% | -54.55% | -52.26% | -4.25% | 29.14% |
| Total Depreciation and Amortization | -2.27% | -12.11% | -18.48% | -15.96% | -13.35% |
| Total Amortization of Deferred Charges | -82.94% | -82.94% | -82.94% | -7.17% | 298.84% |
| Total Other Non-Cash Items | 93.44% | 86.72% | 79.98% | -54.55% | -719.12% |
| Change in Net Operating Assets | 307.14% | 277.24% | 252.45% | 140.63% | -7.06% |
| Cash from Operations | 34.83% | 34.76% | 32.09% | 11.07% | -12.59% |
| Capital Expenditure | 58.85% | 26.24% | -14.98% | -23.01% | -31.99% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -105.49% | -102.05% | -100.38% | -73.69% | -42.12% |
| Cash from Investing | -115.49% | -111.09% | -109.28% | -81.45% | -48.34% |
| Total Debt Issued | -98.50% | -98.50% | -- | -- | -- |
| Total Debt Repaid | 94.85% | 54.78% | -4.03% | -22.25% | -39.58% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 107.74% | 115.89% | 124.50% | 228.38% | 20,000.00% |
| Cash from Financing | -11.16% | 25.91% | 136.86% | 469.49% | 2,795.73% |
| Foreign Exchange rate Adjustments | -354.69% | -142.38% | 11,473.68% | 6,489.22% | 3,504.72% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -87.47% | -89.26% | -91.08% | 55.70% | 457.56% |